Zynerba Pharma CS (ZYNE)
$0.96
0.03 (2.96%)
ZYNE Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Get ready for another busy week of trading as we kick off Monday with a look at the biggest pre-market stock movers for today.
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
41.81M
PE Ratio
-0.65
EPS
-1.47
Volume (Avg. Vol.)
290,496
Day's Range
$0.91 - $1.01
52-Week Range
$0.84 - $6.07
Dividend & Yield
N/A (N/A)
ZYNE Stock Predictions, Articles, and Zynerba Pharma CS News
Zynerba Stock Soars on Cannabidiol Patent for Autism Spectrum Disorder
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
Zynerba Stock Is Marijuana-Adjacent Play Worth a Look
Zynerba has a CBD gel that looks like a promising treatment for various neurological diseases. What does it mean for ZYNE stock?
Zynerba Pharmaceuticals News: Why ZYNE Stock Is Soaring Today
There's some positive Zynerba Pharmaceuticals news concerning ZYNE stock on Tuesday that has it soaring to incredible heights.
2 Marijuana Biotechs to Watch
Things may be looking up for marijuana stocks, as a cannabidiol (CBD)-based drug was rescheduled to Schedule 5. These 2 should profit next.
Zynerba Pharmaceuticals Continues Its 3-Day Rally
Zynerba Pharmaceuticals (ZYNE) stock isn't done with its recent rally yet as the stock continues to climb higher on Thursday.
Market Roasts Shares of Zynerba Pharmaceuticals
Zynerba's stock sank after the company issued shares at $8. This validated the bearish bets against the stock. What should investors expect next?
3 Stocks to Watch on Monday: Alphabet Inc (GOOGL), Zynerba Pharmaceuticals Inc (ZYNE) and Sony Corp (ADR) (SNE)
Zynerba Pharmaceuticals (ZYNE) crashes by nearly half, Alphabet (GOOGL) responds to anti-diversity letter and Sony (SNE) suffers yet another box-office disappointment.
Best Stocks for 2017: Zynerba Pharmaceuticals Inc (ZYNE) Stock Dominates in Q1
Zynerba is working to bring its marijuana-based medications through trials and investors seem to be rewarding ZYNE stock.
Hottest Manufacturing Stocks Now – MBRX ZYNE SID ONVO
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Hottest Manufacturing Stocks Now – DPRX TCON CATB ZYNE
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Best Stocks for 2017: Zynerba Pharmaceuticals Inc (ZYNE) Is a Perfect Prescription
ZYNE stock has a couple of promising therapies in trials that could make 2017 a great year for Zynerba stockholders.
Biggest Movers in Manufacturing Stocks Now – TXMD IMMU LIFE WKHS
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
